Home » Newsletters » BioWorld Science

BioWorld Science

May 12, 2009

View Archived Issues

Hepatitis C vaccine E1E2/MF59C.1 evaluated in difficult-to-treat patients

Ropinirole prolonged release reduces sleep dysfunction in Parkinson's disease in phase III trials

Milnacipran improves cognition and reduces tenderness in patients with fibromyalgia

Fenretinide shows efficacy in treatment of geographic atrophy; preliminary phase II data disclosed

Safety and tolerability of ACU-4429 demonstrated in healthy subjects in phase I trial

Intravitreal ranibizumab safe in phase I/II trial for PCV / News in Context

Prasterone reverses vaginal atrophy in postmenopausal women; phase III data presented

Gabapentin extended release improves quality of sleep in postmenopausal women with hot flashes

Lundbeck's ATryn now available in the U.S. for hereditary antithrombin deficiency

FDA approves Tekmira's IND to initiate phase I clinical trial of ApoB SNALP

Purdue's Ryzolt now available in the U.S. for moderate to moderately severe chronic pain

FDA to review Savient's BLA for Krystexxa for TFG patients in June 2009

TargeGen claims JAK kinase inhibitors for cancer treatment

GlaxoSmithKline claims novel pyridazine derivatives for the treatment of Alzheimer's disease

Janssen describes nicotinic acetylcholine receptor modulators for cognitive disorders

Novel antidiabetic drugs discovered by Novartis

GlaxoSmithKline presents novel glucocorticoid receptor agonists as antiinflammatory agents

DUSA commences trial of Levulan photodynamic therapy in solid organ transplant recipients

FDA approves Lamictal ODT orally disintegrating tablets

PAION completes first part of phase Ib anesthetic/sedative study with CNS-7056

WBI-1001 topical application improves symptoms of psoriasis and atopic dermatitis in phase I trial

Schering-Plough initiates enrollment in phase 3 trial for acadesine

Targacept presents preliminary results from phase II AZD-3480 trial

Tokai closes series D funding round for lead candidate, TOK-001

UCB seeks to acquire remaining 0.4% of the Schwarz Pharma shares

Biotec's second phase III study of SBG proceeds as planned after interim analysis

HRA Pharma and PregLem successfully complete phase IIb study of ulipristal acetate

Inhibitex begins phase II trial of FV-100 for the treatment of shingles

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...